Raymond James Financial Services Advisors, Inc. Sera Prognostics, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 Apr 22, 2024	BUY	$5.05 - $10.0 $103,297 - $204,550	20,455 New	20,455 $186,000

Others Institutions Holding SERA

# of Institutions

Shares Held

20.4M

Call Options Held

120K

Put Options Held

Baker Bros. Advisors LP New York, NY

5.43M
Shares

$26.5 Million
0.45% of portfolio
Ra Capital Management, L.P. Boston, MA

3.03M
Shares

$14.8 Million
0.33% of portfolio
Interwest Venture Management CO

2.42M
Shares

$11.8 Million
21.78% of portfolio
Vivo Capital, LLC Palo Alto, CA

1.65M
Shares

$8.05 Million
1.88% of portfolio
Black Rock Inc. New York, NY

1.41M
Shares

$6.88 Million
0.0% of portfolio

View Full List

About SERA PROGNOSTICS, INC.

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $144M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

More about SERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account